Sonoma Pharmaceuticals, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Sonoma Pharmaceuticals, Inc. (SNOA) on July 27, 2021. The company is incorporated in Delaware and trades on The Nasdaq Stock Market LLC. The report addresses a corporate governance event regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a personnel change and does not contain financial statements or performance data.
Material Changes
The material change reported is the departure of Sharon Barbari from the Board of Directors. Ms. Barbari, who served as a director, chair of the audit committee, and member of the compensation and nominating and corporate governance committee, notified the company that she will not stand for re-election at the upcoming annual meeting of stockholders on September 15, 2021, due to personal reasons. The company confirmed there were no disagreements between Ms. Barbari and the registrant.
Outlook and Management Commentary
Management expressed gratitude for Ms. Barbari's dedicated service of over seven years. The company stated it is currently searching for a new board member to replace her. No financial guidance, risk factors, or contingencies were disclosed in this specific filing.
Key Facts for Investor Verification
- Sharon Barbari is stepping down from the Board of Directors effective at the September 15, 2021, annual meeting.
- Ms. Barbari held key roles including Chair of the Audit Committee.
- The departure is attributed to personal reasons with no reported disagreements.
- The company is actively seeking a replacement director.
- No financial performance data is included in this filing.